Atomic View of Bacterial Enzymes That Help Human Digestion
摘要: 研究人员通过解析人类肠道细菌产生的GH31酶的晶体结构和生化活性,揭示了这些酶在淀粉消化过程中的分子机制,为理解饮食淀粉如何被分解为葡萄糖并影响人体健康提供了原子层面的视角。
- 加拿大滑铁卢大学的研究团队解析了肠道细菌中两种GH31酶的晶体结构,阐明其在淀粉消化中的作用机制。
- 淀粉是人类饮食中主要的多糖来源,其消化过程与糖尿病、肥胖、肝病等多种健康问题密切相关。
- 肠道微生物组通过分泌酶分解淀粉为葡萄糖,直接影响宿主的代谢和健康状态。
- 该研究有助于开发靶向特定淀粉消化酶的药物,以调控血糖水平并治疗相关代谢疾病。
小白老师说:A group of researchers at the University of Waterloo in Ontario, Canada has reached deep into the human gut, plucked out a couple enzymes produced by bacteria residing there and determined their biological activities and molecular structures - details that should shed new light on how we digest many of the foods we eat.**
The question of how starch digestion works is one of great importance to human health because starch is a major component of the human diet. Plants make this polysaccharide molecule during photosynthesis as a way of storing energy, and foods like potatoes, wheat and rice are all rich in starch. It is a major source of dietary glucose, the main sugar the human body uses for fuel.
Dietary glucose and the physiology of starch digestion figures prominently in digestive and liver diseases, food intolerances, diabetes and obesity, and the new work has implications for all these conditions as well as other areas of human health.
In the last few years, scientists have come to appreciate the outsized role played in healthy gut physiology by a rich ecosystem of “good” bacteria residing in the gut - referred to collectively as the gut microbiome. Whenever we eat vegetables, enzymes produced by these bacteria break the starch molecules down into smaller component pieces, like glucose, which are then absorbed through the gut into the bloodstream.
The makeup of the organisms in the gut microbiome has been a hot topic because of these linkages to human health, and earlier studies have shown how altering the microbiome of mice directly affects their weight, turning fat mice thin and vice versa. Major research projects started in the United States and elsewhere are aiming to identify and analyze all the micro-organisms in the human gut.
The University of Waterloo team, led by David Rose, has been working out the detailed molecular mechanisms for individual enzymes and other molecules involved in starch digestion. They are looking at component pieces of large complexes of molecules known as starch utilization systems, one of the two major systems in the intestinal microbiome helping to break down starch.
At the American Crystallographic Association (ACA) 2015 Meeting, which will be held in Philadelphia from July 25-29, 2015, Rose’s graduate student, Marcia Chaudet will present biochemical activity data as well as crystal structures of two proteins known as GH31 enzymes that help to break down starch as part of these starch utilization systems.
“Based on the structures we have so far, we can make predictions about specificity,” said Rose. “Such structural information can reveal subtle points about the physiology that would otherwise be hidden and may be impossible to predict. It can also guide the development of chemical compounds [a basic approach to pharmaceutical drug development].”
This is significant, he added, because if you can figure out which enzymes are primarily responsible for binding to and digesting starch, then you might be able to design drugs that would fine-tune that activity, allowing you to better regulate blood glucose levels and address diseases where this physiology is at play
常见问题
这项研究如何帮助理解人类消化过程?
研究通过解析肠道细菌产生的GH31酶的原子结构,揭示了它们如何特异性识别并分解淀粉,从而在分子层面阐明了人类对植物性食物中淀粉的消化机制。
为什么肠道细菌对淀粉消化如此重要?
人体自身产生的淀粉酶无法完全分解所有类型的淀粉,而肠道“好”细菌产生的酶能进一步降解复杂淀粉为可吸收的葡萄糖,对能量获取和代谢健康至关重要。
这项研究对糖尿病或肥胖症有何潜在意义?
通过了解哪些细菌酶主导淀粉消化,未来可能设计药物调节这些酶的活性,从而控制葡萄糖释放速率,帮助管理血糖和体重相关疾病。
参考资料
American Crystallographic Association (ACA) 2015 Meeting Presentation by Marcia Chaudet and David Rose
研究结果于2015年7月在美国费城举行的美国晶体学协会年会上由滑铁卢大学团队报告。
Role of gut microbiota in starch digestion and metabolic health
多项研究表明肠道微生物组组成与宿主代谢疾病(如肥胖、糖尿病)密切相关,支持本研究的生理背景。